Empagliflozin, health status, and quality of life in patients with heart failure and preserved ejection fraction: the EMPEROR-Preserved trial
Butler J, Filippatos G, Siddiqi TJ, et al.
Circulation. 2022;145(3):184-193
Leggi
Butler J, Filippatos G, Siddiqi TJ, et al.
Circulation. 2022;145(3):184-193
Leggi
Berg DD, Docherty KF, Sattar N, et al.
Circulation. 2022;145(3):158-169
Leggi
25 gennaio 2022
Leggi
Barrett CE, Koyama AK, Alvarez P, et al.
MMWR Morb Mortal Wkly Rep. 2022;71(2):59-65.
Leggi
Lyu B, Grams ME, Chang A, et al.
Am J Cardiol. 2022;165:124-130.
Leggi
Ekhlaspour L, Town MA, Raghinaru D, et al.
Diabetes Technol Ther. Pub. online 12 January 2022
Leggi
Uemura F, Okada Y, Mita T, et al.
Diabetes Technol Ther. Pub. online 20 January 2022.
Leggi
Wan SH, Slusser JP, Hodge DO, Chen HH
Am J Cardiol. 2022;165:65-71
Leggi
Joseph JJ, Deedwania P, Acharya T, et al.
Circulation. 2022;CIR0000000000001040
Leggi